RATIONALE: Atopic dermatitis (AD) is a chronic relapsing inflammatory skin disease. Single nucleotide polymorphisms (SNPs) in KIF3A, the gene encoding Kinesin family member 3A, have been associated with AD and asthma, but the mechanistic basis underlying these associations remains unclear. METHODS: We investigated the mechanistic basis of the genetic contribution of KIF3A using human and mouse studies. Individuals carrying 1 or 2 copies of rs11740584 and rs2299007 alternate alleles were recruited and SNP methylation and allele-specific gene expression was determined in nasal airway cells. Skin barrier function was determined in rs11740584 and rs2299007 alternate allele carriers and Kif3a skin specific knockout mice. RESULTS: KIF3A SNPs rs2299007 and rs11740584 generate new CpG sites, which are methylated in individuals carrying the alternate alleles. Allele-specific PCR confirmed lower KIF3A expression from the alternate allele. Methylation levels were associated with unbalanced expression of skin barrier genes FLG and LOR, and with increased transpidermal water loss (TEWL). Kif3a K14D/D mice had increased TEWL and epidermal thickness, and dysregulation of skin barrier genes Flg and Claudin-1. Further, Kif3a K14D/D mice demonstrated increased susceptibility to develop AD following cutaneous allergen exposure. CONCLUSIONS: Our data provide a mechanistic basis for the AD disease susceptibility conferred by KIF3A SNPs rs2299007 and rs11740584. The alternate alleles generate novel CpG sites resulting in increased methylation and decreased expression of KIF3A leading to skin barrier dysfunction. KIF3A is required for skin barrier homeostasis, and decreased KIF3A expression in skin causes increased TEWL and dysregulation of skin barrier genes, and promotes development of AD.
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Mast cell-dependent adjuvant activity is a key component of the respiratory immune response to inhaled Alternaria RATIONALE: Exposure and sensitization to Alternaria alternata (Alternaria) is strongly associated with asthma development, persistence, and exacerbations. Alternaria elicits murine and human mast cell (MC) activation, independent of IgE receptor signaling, but the relevant fungal ligand, mechanism of activation, and potential for adjuvanticity have not been characterized. METHODS: Alternaria fractions were obtained using sequential saltingout fractionation, ion-exchange, and size-exclusion chromatography, and tested for activity on murine bone marrow-derived MCs (BMMCs). Putative MC ligands from active fractions were identified using Massspectroscopy and cloned for recombinant expression. WT and Mcpt5/ DTA mice, with diptheria toxin-mediated MC deletion, were treated with intranasal Alternaria and dendritic cell (DC) activation and lung inflammation was assessed at serial timepoints. RESULTS: In response to Alternaria inhalation, IgE-independent MC activation not only potentiates pulmonary inflammation but also regulates the migration of antigen-bearing DCs to regional lymph nodes to mediate the earliest events in aeroallergen sensitization. Partial purification of Alternaria extracts demonstrates that MC degranulation and CysLT generation is elicited by a weakly-anionic heat-labile protein (30-50kDa in size) and is protease-independent. Mass-spectroscopy and cloning have identified several novel fungal candidate proteins that have not been previously characterized. CONCLUSIONS: Although several Alternaria allergens have been identified, the adjuvant activities of most fungal proteins remain poorly characterized. We find that a novel Alternaria Ag acts as a danger signal to initiate innate MC-dependent sensitization and subsequent pulmonary inflammation. These findings highlight the role of innate MC sensing in the respiratory tract and the importance of MC-DC crosstalk in priming for allergen-elicited inflammation.
